Page last updated: 2024-08-21

aminoimidazole carboxamide and Pulmonary Disease, Chronic Obstructive

aminoimidazole carboxamide has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, XG; Liu, B; Ma, LJ; Qi, Y; Shang, JY; Sun, BB; Zhang, GJ1
Cheng, XY; Huang, C; Li, J; Li, YY; Yao, HW1

Other Studies

2 other study(ies) available for aminoimidazole carboxamide and Pulmonary Disease, Chronic Obstructive

ArticleYear
Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD rats.
    Respiratory research, 2014, Dec-07, Volume: 15

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Down-Regulation; Gene Expression Regulation, Enzymologic; Male; Muscle Weakness; Muscle, Skeletal; Pulmonary Disease, Chronic Obstructive; Rats, Wistar; Resveratrol; Ribonucleotides; RNA, Messenger; Sirtuin 1; Stilbenes; Time Factors; Tumor Necrosis Factor-alpha

2014
AMP-activated protein kinase reduces inflammatory responses and cellular senescence in pulmonary emphysema.
    Oncotarget, 2017, Apr-04, Volume: 8, Issue:14

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line; Cellular Senescence; Energy Metabolism; Female; Humans; Inflammation; Lipid Metabolism; Lung; Male; Mice; Mice, Inbred C57BL; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrazoles; Pyrimidines; Respiratory Mucosa; Ribonucleotides; Smoking

2017